找不到产品?留下需求帮您找
一键询价UPCISCC090 人舌头鳞癌细胞 QCH766
7天
3500¥
KNS62 人肺支气管鳞状细胞癌 QCH767
7天
3500¥
HCC95 人肺腺癌细胞 QCH768
7天
3500¥
HARA 人肺腺癌细胞 QCH769
7天
3500¥
EPLC272H 人肺腺癌细胞 QCH770
7天
4000¥
NCI-H810 人非小细胞肺癌细胞 QCH771
7天
5000¥
HBL-1 人弥漫性大B细胞淋巴瘤 QCH772
7天
1800¥
FTC238 人滤泡状甲状腺癌细胞,肺转移 XY-H773
7天
3500¥
SNU-719 人胃癌细胞 QCH774
7天
3500¥
BT549+GFP+LUC 人乳腺癌细胞 QCH766GL
钦诚生物 | 一周
4500¥
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:Nifuroxazide 产品别名:见爱必信官网 英文别名:Nifuroxazide 靶点:STAT CAS:965-52-6 纯度:>98% 外观:见爱必信官网 保存方法:-20°C 描述: Nifuroxazide是硝基呋喃类化合物抑制剂,有效地抑制细胞内STAT1/3/5转录活性的激活,IC50为3 μM。Nifuroxazide通过减少Jak激酶自身磷酸化阻碍了STAT3组成型磷酸化,从而降低骨髓瘤细胞存活性,而不影响正常的外周血单核细胞。硝呋齐特能够降低Jak和TYK2的酪氨酸磷酸化,而对EGF受体酪氨酸激酶或Src激酶没有影响,表明硝呋齐特对Jak2和TYK2的相对特异性。Nifuroxazide会引起包含STAT3活化的初级骨髓瘤细胞和骨髓瘤细胞系的存活性降低,但不影响正常外周血单核细胞。 溶解性:DMSO :51 mg/mL (185.3 mM) 体外研究: Nifuroxazide is a nitrofuran compound inhibitor of STAT transcription factor signaling. Nifuroxazide is described to block constitutive phosphorylation of STAT3 by reducing Jak kinase autophosphorylation, decreasing the viability of myeloma cells depending on constitutive STAT3 activity for survival while not affecting normal peripheral blood mononuclear cells. Nifuroxazide produces decreases in tyrosine phosphorylation of Jak2 and Tyk2, and showed no effects on EGF receptor tyrosine kinase or Src kinase, indicating a relative specificity of Nifuroxazide for Jak2 and Tyk2. Nifuroxazide shows no inhibition of Akt or MAPK phosphorylation. Nifuroxazide inhibits the constitutive phosphorylation of STAT3 in MM cells by reducing Jak kinase autophosphorylation, and leads to down-regulation of the STAT3 target gene Mcl-1. Nifuroxazide causes a decrease in viability of primary myeloma cells and myeloma cell lines containing STAT3 activation, but not normal peripheral blood mononuclear cells. Although bone marrow stromal cells provide survival signals to myeloma cells, nifuroxazide can overcome this survival advantage. Reflecting the interaction of STAT3 with other cellular pathways, nifuroxazide shows enhanced cytotoxicity when combined with either the histone deacetylase inhibitor depsipeptide or the MEK inhibitor UO126. 体内研究:
产品信息订购:
|
Nifuroxazide多少钱?
爱必信生物分子的应用资料有吗?
爱必信生物分子货号abs813745报价含票含运吗?
爱必信货号abs813745货期是多久?
爱必信Nifuroxazide可以申请试用吗?
爱必信爱必信生物分子售后政策是什么?
Nifuroxazide有现货吗?